Clinical trials
Basal Cell Carcinoma trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2007 | 2 |
| 2011 | 5 |
| 2012 | 4 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2021 | 5 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Withdrawn | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Rochester | 4 |
| University of California, Davis | 2 |
| Albert Einstein College of Medicine | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Anne Chang | 1 |
| Case Comprehensive Cancer Center | 1 |
| Christopher Zachary | 1 |
| East Tennessee State University | 1 |
| Emory University | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Basal Cell Carcinoma | 34 |
| Carcinoma, Squamous Cell | 14 |
| Melanoma | 10 |
| Skin Neoplasms | 7 |
| Anxiety Disorders | 1 |
| Basal Cell Nevus Syndrome | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Merkel Cell | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Renal Cell | 1 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.